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Background and Purpose—Intracranial thrombi can be characterized according to their permeability as measured 
by contrast agent penetration. Thrombus composition and its associated pathogenesis are important factors affecting 
treatment and secondary prevention. We aimed to explore the histopathologic factors explaining the heterogeneity of 
thrombus permeability measures and evaluated potential correlations with stroke pathogenesis.
Methods—Thrombus densities were measured in thin-slice noncontrast computed tomography and automatically aligned 
computed tomographic angiography images of 133 patients with large-vessel occlusions of the middle cerebral artery. 
Change in thrombus attenuation (Δ
t
) and corrected void fraction (ε; attenuation increase corrected for contralateral artery 
densities) were calculated. First, these thrombus perviousness measures were correlated with histological thrombus 
components (especially fractions of fibrin-platelet accumulation and red blood cells) and stroke pathogenesis (n=32). For 
validation, an association between perviousness and pathogenesis was assessed in a second, independent cohort (n=101).
Results—Thrombus perviousness estimates were correlated with both fibrin/platelets fractions (Δ
t
: r=0.43, P=0.016/ε: 
r=0.45, P=0.01) and inversely with red blood cells counts (Δ
t
: r=−0.46, P=0.01/ε: r=−0.49, P=0.006). In the first 
cohort, Δ
t
 was substantially higher in samples from patients with cardioembolic stroke pathogenesis as compared 
with noncardioembolic-derived thrombi (P=0.026). In the validation cohort, thrombus perviousness measures differed 
significantly between cardioembolic (Δ
t
: median [ interquartile range]=12.53 [8.70–17.90]; ε: median [interquartile 
range]=0.054 [0.036–0.082]) and noncardioembolic thrombi (Δ
t
: median [interquartile range]=3.2 [2.17–6.44], P<0.001; 
ε: median [interquartile range]=0.020 [0.011–0.027], P<0.001) and were associated with pathogenesis (Δ
t
: β=0.45, 
P=0.016/ε: β=83.6, P=0.013) in a binary logistic regression model.
Conclusions—Permeable thrombi showed a strong correlation with lower fractions of red blood cells counts and more 
fibrin/platelets conglomerations, concurrent with an association with cardioembolic origin. This novel information about 
thrombus perviousness may be valuable as a new and simple to acquire imaging marker for identifying stroke pathogenesis 
using early and readily available imaging.   (Stroke. 2018;49:2674-2682. DOI: 10.1161/STROKEAHA.118.021873.)
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The first clinical assessment of acute ischemic stroke requires urgent imaging that is primarily realized by 
computed tomography (CT) and computed tomographic an-
giography (CTA) because of their wide availability. In addi-
tion to the localization of vessel occlusion, the thrombus can 
be imaged directly. Characteristics, such as length, density, 
or perviousness of the thrombus, can be assessed, all of 
which have been associated with recanalization rates and 
functional outcome.1–6
The underlying factors accounting for the heterogeneity 
of thrombus appearances on CT imaging have not yet been 
clarified. However, a correlation of thrombus appearance with 
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histological parameters is assumed. In particular, an associ-
ation between the hyperdense middle cerebral artery sign 
and red blood cell (RBC) content of the thrombi has been 
observed.7
Endovascular mechanical thrombectomy, the current 
standard therapy for large-vessel occlusions of the anterior cir-
culation,8–12 allows for investigation of thrombus consistency 
and histology. An evaluation of the histological composition 
of ex vivo thrombi was previously conducted and defined the 
main histological thrombus components as fibrin/platelet (FP) 
conglomerations and RBC, supplemented by a small fraction 
of white blood cells (WBC).7,13–17
The correlation with underlying clot pathogenesis13,18 and 
the effect of clot composition on mechanical recanalization 
procedures were examined.19–21 An analysis of artificial clots 
showed a strong association of fibrin content and contrast 
agent uptake,22 but the relationship of ex vivo thrombi to per-
meability measures in admission imaging is unclear.
Permeability is quantified by the level of contrast pene-
tration, using derived metrics, such as change in thrombus 
attenuation and void fraction as thrombus perviousness 
measures, which have been associated with functional out-
come and recanalization status.1 The use of arterial-phase 
CTA appeared to be most suitable for the measurement 
of thrombus perviousness when compared with delayed 
phases.23
The assessment of perviousness measures is easy to im-
plement during admission imaging of patients with stroke that 
consists of noncontrast CT (nCT) and CTA imaging and has 
the potential to give additional information about the occlud-
ing thrombus.
The present study aimed to further investigate the under-
lying factors of thrombus perviousness in admission CT im-
aging by investigating a possible correlation with histological 
composition. Based on the known correlation of histological 
composition with underlying clot pathogenesis,13 an associa-
tion of thrombus perviousness to pathogenesis was tested in 
a second, independent subcohort. Better characterization of 
thrombi might have a beneficial impact on the clinical man-
agement of patients with acute ischemic stroke and in deci-
sions on secondary prevention.
Materials and Methods
The authors declare that all supporting data are available within the 
article and its online-only Data Supplement.
As a primary end point, a possible correlation between 
thrombus perviousness measures and percentages of the main 
histological thrombus component FP conglomerations, RBC, and 
WBC counts were examined in the first group, labeled histological 
cohort. Further assessment was done to see whether the association 
between histology and stroke pathogenesis, which is known from 
the whole in vivo thrombus cohort, could also be determined in 
the analyzed subgroup by showing a correlation between thrombus 
perviousness and stroke pathogenesis. For further validation pur-
poses, the association of stroke pathogenesis with thrombus per-
viousness was tested in a second independent group of patients, 
labeled validation cohort.
This study was approved, and the need for patient consent was 
waived by our local ethics committee, in accordance with the eth-
ical standards of the 1964 Declaration of Helsinki and its later 
amendments.
Patient Characteristics and Clot Collection
The histological cohort (n=32) was derived from a study sample of 145 
patients with acute ischemic stroke, whose intracranial thrombi were col-
lected between October 2010 and September 2012 during endovascular 
recanalization therapy, as previously described.13 A subcohort was de-
fined by applying prespecified inclusion criteria to obtain a homogenous 
collective of patients with stroke. Inclusion criteria were determined as 
follows: acute, singular, complete occlusion of the middle cerebral artery 
in the M1-segment or a proximal M2-segment with a large-vessel lumen; 
sufficient preinterventional imaging including nCT and immediately 
acquired arterial CTA with a thickness ≤3 mm, respectively; complete 
vessel occlusion without proof of residual blood flow, evaluated by a 
neuroradiologist with at least 2 years' experience (blinded).
The validation cohort (n=101) consisted of all patients with acute 
ischemic stroke who were treated in our department between January 
2015 and December 2017 after applying the same inclusion criteria 
as described above.
Exact numbers and reasons for exclusion in both cohorts are sum-
marized in the study flow chart presented in Figure 1. Basic demo-
graphic, clinical, and interventional data of patients were gathered. 
Stroke pathogeneses were determined according to the international 
TOAST (Trial of ORG 10172 in Acute Stroke Treatment) classifica-
tion24 on the basis of diagnostic and clinical information available for 
each patient, including CT and CTA imaging, magnetic resonance 
imaging, transcranial and extracranial duplex sonography, coagula-
tion tests, long-term electrocardiography recording, and transthoracic 
or transesophageal echocardiography.21
Histological Analysis of Clots
Formalin-fixed and paraffin-embedded thrombi were sectioned in 
2-μm-thick slides followed by hematoxylin-eosin staining and high-
resolution scanning of the slides as previously described.21 Based on 
color-guided segmentation, quantitative analysis of the main compo-
nents (FP, RBC, and WBC as fractions in per cent) was done using 
custom-made quantification software (CAMPThrombus 1.0; not 
commercially available), which has been previously explained in 
more detail.25 In the case of thrombus fragmentation, all fragments 
were included for histological analysis.
Thrombus Perviousness Assessment
Thrombus perviousness was assessed by contrast agent uptake in arte-
rial CTA imaging, measured by the increase of Hounsfield units (HUs) 
between the nCT and CTA scans.1,26 As a first step, the nCT scans were 
automatically aligned with the CTA scans, which were acquired one 
immediately after the other, using a rigid registration method.27 The 
alignment was assessed by a neuroradiologist with at least 2 years’ ex-
perience (blinded). The thrombus was manually segmented in the best 
fitting, axial slice on the overlaid CT images by a neuroradiologist with 
at least 2 years’ experience, and blinded to all clinical data. Hereby, the 
stop of contrast agent in CTA and a possibly existing hyperdense vessel 
sign in nCT scan were used. In consideration of appositional thrombus 
growth, measuring points were placed 1.5 mm behind the occlusion 
site (Figure 2). Assessed volumes as well as HUs of aligned nCT and 
CTA images were extracted. As previously described,1 the difference 
in mean HUs between nCT and CTA is defined as change in thrombus 
attenuation (Δ
t
=Δ within the thrombus). As a reference, the HUs in a 
corresponding position of the contralateral, not occluded, vessel were 
also measured, calculating the difference between nCT and CTA in the 
contralateral artery (Δ
c
). According to Santos et al,1 a thrombus void 
fraction (ε) was calculated as the ratio of change in thrombus attenua-




). In the rare case 
of similar density values in nCT and CTA scans with slightly higher 
values in nCT scans (presumably caused by partial volume effect), this 
small difference was set to zero. To test for observer influence, a neuro-
radiologist with at least 3 years’ experience, blinded to clinical data and 
the analysis performed, repeated the measurements for 10 randomly 
selected patients, followed by an analysis of the root mean square devi-
ation of the HUs in nCT and CTA scans within the thrombus resulting 
only in a relative root mean square error of 1.05%.
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Statistical Analysis
Partial Spearman rank order correlations were performed between 
histological parameters and perviousness measures Δ
t
 and ε, con-
trolling for the volume of thrombus assessment. Wilcoxon rank-sum 
tests were used for comparison of thrombus perviousness between 
etiological subgroups. Binary logistic regression was performed to 
test a possible prediction of stroke pathogenesis by thrombus per-
viousness, controlling for the volume of thrombus assessment and 
patient age. Receiver operating characteristic (ROC) analyses were 
implemented to identify a threshold beyond which perviousness 
measurements might show reasonable discriminatory power to in-
dicate the cardioembolic origin of the thrombus. Pathogenesis was 
assessed by TOAST criteria, as mentioned above. Additional analy-
ses were performed with dichotomized etiological groups, defined 
by noncardioembolic (TOAST 1+4) and mainly cardioembolic clots 
(TOAST 2+5), based on previous histological results.13,18 To test for 
the reported dependency of density measurements on slice thick-
ness,28 Spearman rank order correlations were calculated between 
slice thickness and density measurements in the validation cohort. 
Hypothesis testing was run with exploratory, 2-sided 5% signifi-
cance levels. All statistical analyses were performed using IBM 
SPSS Statistics (version 24, IBM Corp, Armonk, NY).
Results
Patient Characteristics
In total, 133 patients (32 in the histological cohort, 101 in 
the validation cohort) met the required inclusion criteria as 
indicated in Figure 2. Recanalization success, clinical out-
come data, and assessed TOAST criteria are summarized in 
the Table.
Perviousness Shows Correlation With 
Histological Thrombus Composition
Median fractions of the quantified thrombus components 
were as follows: FP (median, 56%; interquartile range [IQR], 
Figure 1. Study flow chart: exact numbers and reasons for exclusion in the histological and validation cohorts. CTA indicates computed tomographic angi-
ography; and nCT, noncontrast computed tomography.
Figure 2. Example of measurements of 
thrombus density in automatically aligned 
noncontrast computed tomography (left, mean 
Hounsfield units [HU]=64.7) and computed to-
mographic angiography images (right, mean 
HU=92.0) of a patient with acute M1 vessel 
occlusion with known atrial fibrillation.
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44%–69%), RBC (median, 39%; IQR, 27%–52%), and WBC 
(median, 5%; IQR, 4%–7 %). Perviousness measurements Δ
t
 
(median, 9.6; IQR, 0.37–17.1) and ε (median, 0.042; IQR, 
0.002–0.062) as well as volume of thrombus assessment (me-
dian, 6.92 mm3; IQR, 4.93–10.01 mm3) and volume of the mea-
surements in the not-occluded contralateral vessel (median, 
8.21 mm3; IQR, 5.47–14.02 mm3) were gathered. Quantified 
thrombus components correlated with perviousness measure-
ments as evidenced by a significant positive correlation for 
FP (Δ
t
: r=0.43, P=0.016/ε: r=0.45, P=0.01), a significant neg-
ative correlation for RBC (Δ
t
: r=−0.46, P=0.01/ε: r=−0.49, 
P=0.006; Figure 3) and a positive correlation for WBC (Δ
t
: 
r=0.34, P=0.06/ε: r=0.38, P=0.04; Figure 3).
Perviousness Shows Association With Stroke 
Pathogenesis in the Histological Cohort
Based on the known correlation between thrombus his-
tology and stroke pathogenesis13 with higher fractions of FP 
conglomerations in thrombi of cardioembolic origin, a cor-
responding association between histology and perviousness 
was expected. Despite the small sample size, we observed 
differences in perviousness measures between cardioembolic 
(Δ
t
: mean, 11.90, median, 9.95, IQR, 0–19.16/ε: mean, 0.049, 
median, 0.050, IQR, 0–0.065) and noncardioembolic thrombi 
(Δ
t
: mean, 2.45, median, 0, IQR, 0–6.14, P=0.088/ε: mean, 
0.016, median, 0, IQR, 0–0.04, P=0.16). After dichotomizing 
TOAST 2 and 5 together, these mainly cardioembolic thrombi 
(Δ
t
: mean, 12.51, median, 11.57, IQR, 2.94–17.51/ε: mean, 
0.051, median, 0.050, IQR, 0.015–0.065) showed significant 
differences compared with the noncardioembolic thrombi (Δ
t
: 
mean, 2.45, median, 0, IQR, 0–6.14, P=0.026/ε: mean, 0.016, 
median, 0, IQR, 0–0.04, P=0.087). The higher perviousness 
for (mainly) cardioembolic thrombi is in line with the pres-
ence of higher fractions of FP and lower fractions of RBC 
conglomerations in those thrombi.
 The distributions of Δ
t
 and ε in the etiological groups are 
presented in Figure 4.
Perviousness Is Associated With Stroke Pathogenesis 
in a Large Independent Validation Analysis
The distribution of the perviousness measurements Δ
t
 
and ε for the different etiological subgroups is shown in 
Figure 5. Thrombus perviousness measures of cardioembolic 
thrombi (Δ
t
: median [IQR]=12.53 [8.70–17.90]; ε: median 
[IQR]=0.054 [0.036–0.082]) were significantly higher than 
those of noncardioembolic thrombi (TOAST 1+4) (Δ
t
: me-
dian [IQR]=3.2 [2.17–6.44], P<0.001; ε: median [IQR]=0.020 
[0.011–0.027], P<0.001) but showed no significant differ-
ences in comparison to cryptogenic thrombi (Δ
t
: median 
[IQR]=11.6 [6.3–19.3], P=0.46; ε: median [IQR]=0.049 
[0.029–0.088], P=0.51). After dichotomizing the etiolog-
ical subgroups according to,13 mainly cardioembolic thrombi 
(TOAST 2+5) showed higher perviousness measures (Δ
t
: 
median [IQR]=12.37 [7.26–17.91]; ε: median [IQR]=0.052 
[0.032–0.083]) compared with noncardioembolic thrombi 
(median [IQR]: see above, Δ
t
/ε: P<0.001).
In a binary logistic regression model, dichotomized 
TOAST criteria (cardioembolic versus noncardioembolic, 
covariates: volume of thrombus and age of patients) were 
predicted by Δ
t
 (β=0.45, P=0.016). Similar results were also 
found for ε (β=83.6, P=0.013).
ROC analysis for perviousness measures Δt and ε indi-
cated that these parameters are significant indicators of car-
dioembolic stroke pathogenesis (for Δt: area under the curve 
0.92 [95% CI, 0.85–0.99], P<0.0001; for ε: area under the 
curve 0.86 [95% CI, 0.76–0.96], P<0.0001; Figure I in the 
online-only Data Supplement). According to the ROC anal-
ysis, a specificity of 100% to categorize a thrombus as car-
dioembolic would be reached for a cutoff value of >8.21 HU 
for Δt (specificity 100%, at a sensitivity of 79%) and a cutoff 
value of >5.6% for ε (specificity 100%, at a sensitivity of 
46.2%). A higher sensitivity would be reached by defining a 
cutoff value of >4.8% for ε with a small loss of specificity 
(specificity 92.3%, at a sensitivity of 61.5%; Figure I in the 
online-only Data Supplement).
With an a priori probability (prevalence) of cardioem-
bolic pathogenesis of 80%, classifying a thrombus with Δt 
>8.21 HU as cardioembolic corresponds to a positive pre-
dictive value of 100%. The detailed statistical values can be 
Table. Baseline Clinical Parameters, Recanalization Outcome, and Assessed 






Age, y, median (IQR) 73 (65–81) 78 (71–86)
Sex, n (female/male) 18/14 49/52
TICI score post recanalization, n
  0 0 12
  1 0 1
  2a 3 5
  2b 12 32
  3 17 50
Additional intravenous 
thrombolysis, n (%)
20 (62.5%) 48 (47.5%)
NIHSS, median (IQR)
  Pre-treatment 15 (10–17) 14 (10–18)
  Post-treatment 5 (0–8) 6 (1–12)
  Difference pre-post-
treatment
8.5 (3–12) 7 (2–11)
mRS score (90 d)
  0–2 9 23
  >2 9 28
TOAST
  Arterioembolic (TOAST 1) 4 12
  Cardioembolic (TOAST 2) 19 52
  Other determined cause 
(TOAST 4)
1 1
  Cryptogenic (TOAST 5) 8 36
IQR indicates interquartile range; mRS, modified Rankin Scale; NIHSS, 
National Institutes of Health Stroke Scale; TICI, Thrombolysis in Cerebral 
Infarction; and TOAST, Trial of ORG 10172 in Acute Stroke Treatment.
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found in Table I of the online-only Data Supplement. The 
control analysis to address the impact of CT slice thick-
ness on the analyses showed no significant correlation be-
tween measured densities and slice thickness (nCT: r=−0.14, 
P=0.15; CTA: r=−0.15, P=0.15) nor between perviousness 
measurements and slice thickness (Δ
t
: r=0.06, P=0.55; ε: 
r=0.03, P=075).
Discussion
In the present study, permeable thrombi consisted of less RBC 
and increased FP conglomerations. 
Because of known correlations between fibrin dominance 
and cardioembolic origin,13,18 an association of thrombus per-
viousness with stroke pathogenesis was tested in one cohort, 
in which histological and imaging parameters were available 
for analysis. We found that more organized cardioembolic 
thrombi showed a higher perviousness. To validate the poten-
tial association of thrombus perviousness and cardioembolic 
pathogenesis, we confirmed our findings in a second, inde-
pendent cohort with a larger sample size.
Because endovascular procedures as standard treat-
ments for large intracranial vessel occlusions have a proven 
Figure 3. Correlation between change in thrombus attenuation (Δt; left) or void fraction (ε; right) and quantified thrombus components (fibrin/platelet [FP], 
red blood cell [RBC], and white blood cell [WBC] in %) in the histological cohort.
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efficacy over best medical treatment alone,8–12,29 questions 
arise on the optimal endovascular techniques, which may 
be guided by directly assessing thrombus characteristics. 
These characteristics can be assessed with admission im-
aging, which is still typically CT imaging because of its 
wide availability (eg, thrombus density measurements4). 
The assessment method for thrombus perviousness of quan-
tifying the level of contrast penetration in CTA imaging is 
well established and has shown a strong impact on func-
tional outcome and recanalization rate after endovascular 
treatment and pharmacological therapy.1,30,31 However, the 
underlying characteristics that determine how the diversity 
of acute thrombi affects perviousness have not been ana-
lyzed. A previous analysis with artificial clots showed a 
strong association of fibrin content and contrast agent up-
take.22 To investigate such an association in patients with 
acute ischemic stroke, we selected a well-defined subgroup 
with only complete occlusions of the middle cerebral ar-
tery. This resulted in a homogenous cohort with direct con-
tact from fresh flooding contrast agent in CTA preventing 
the problem of a stationary blood column, which can be 
observed in occlusions of the internal carotid artery, for ex-
ample. An analysis in multiphase CTA imaging was previ-
ously performed to resolve the time issue but showed an 
optimal association between perviousness and functional 
outcome on arterial-phase CTA, rather than delayed phases, 
which we have not used in our cohort.23
Despite a certain statistical spread in our results, an asso-
ciation of thrombus perviousness with the main constituents 
FP and RBC was shown in the histological study cohort. The 
fibrin-rich thrombus, assumed to have a higher degree of or-
ganization,13 seems to allow the contrast agent to penetrate 
the clot more easily, which fits with the results of previous 
studies on artificial thrombi.22 Lower perviousness was shown 
for thrombi with higher fractions of RBC, assuming a tightly 
packed conglomerate with high concentrations of hemoglobin 
and accordingly high attenuation in nCT,16 which would plau-
sibly impede blood and contrast agent penetration.
A weak positive correlation was found between thrombus 
perviousness and WBC fraction. This result should be con-
sidered with caution because of the small WBC proportion 
of thrombus composition with fractions distinctly <10% and 
consequently higher susceptibility to errors in quantification.13 
Possibly, immunologic mechanisms occurring during an acute 
ischemic stroke32,33 as well as the migration of leucocytes 
could lead to a modification of thrombus structure, affecting 
the degree of perviousness.
Based on previous histological analyses of retrieved 
thrombi,13,18 an association between lower fractions of RBC 
counts and higher FP conglomerations with cardioembolic or-
igin is known. In the present study, these fibrin-rich thrombi 
presented with higher perviousness. Consequently, a correla-
tion between pathogenesis and thrombus perviousness was to 
be expected in this cohort. The current analysis consisted of a 
Figure 4. Boxplots of change in thrombus attenuation (Δt; left) and void fraction (ε; right) for the etiological groups (according to TOAST [Trial of ORG 10172 
in Acute Stroke Treatment]: 1=arterioembolic, 2=cardioembolic, 4=other determined cause, 5=cryptogenic) in the histological cohort.
Figure 5. Boxplots of change in thrombus attenuation (Δt; left) and void fraction (ε; right) for the etiological groups (according to TOAST [Trial of ORG 10172 
in Acute Stroke Treatment]: 1=arterioembolic, 2=cardioembolic, 4=other determined cause, 5=cryptogenic) in the validation cohort.
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well-defined subcohort of the in vivo thrombi after applying 
inclusion criteria (Figure 1). Despite this deviation in sample 
composition, the expected correlation with higher pervious-
ness for cardioembolic thrombi could be shown.
In a second step, the new findings of thrombus pervious-
ness as a marker for thrombus composition and presumably 
thrombus pathogenesis were validated in a larger independent 
cohort by testing the association between perviousness and 
pathogenesis. A possible prediction of cardioembolic origin 
by perviousness was found. This fits the results of prior per-
formed histological analysis showing an association of higher-
organized, fibrin-rich, presumably cardioembolic thrombi 
with higher perviousness.
The ultimate goal of such an approach would be the pos-
sibility to make inferences on stroke pathogenesis using the 
assessment of thrombus perviousness in individual patients. 
The ROC analysis with a selected cutoff value of Δt >8.21 HU 
resulted in a positive predictive value of 100%. The selected 
cutoff value obviously must be validated in independent pa-
tient cohorts, and superiority to the no information rate has 
to be shown in larger samples. However, in the future, this 
simple approach may serve as an additional tool in the diag-
nostic work up of patients with cryptogenic strokes also in 
individual patients.
In previous studies, similar characteristics were demon-
strated for cardioembolic and cryptogenic strokes, assuming 
cardioembolic origins for the latter.13,18 In the comparison of 
perviousness measurements, cardioembolic and cryptogenic 
thrombi also appeared to be similar with a minimal trend to-
ward lower values within the cryptogenic group. This is rea-
sonable when considering that thrombi of unknown cause 
would be preferential of cardioembolic origin, but indeed, 
include undetected causes of arterioembolic strokes or other 
noncardioembolic causes with lower values shown in the cur-
rent analysis.
Different thrombus compositions have a strong impact 
on thrombus stability and mechanical recanalization proce-
dure, as was shown in previous studies.19–21 Preinterventional 
imaging characterization of these thrombi was previously 
done, indicating an association of the appearance of hyper-
dense middle cerebral artery signs in CT or blooming arti-
facts in magnetic resonance imaging with the RBC content 
of the thrombi.7 In contrast to the previously mentioned his-
tological studies,13,18 which follow a more descriptive and by 
peri-interventional gained histology-driven approach, the ac-
tual study, while using histology, evaluates a further imaging 
marker to preinterventionally characterize the thrombi by 
perviousness, which could provide information about the un-
derlying stroke mechanism. In the clinical setting, assessing 
thrombus characteristics in admission imaging could provide 
relevant information that might be helpful in intraoperative 
management on technical aspects of mechanical recanaliza-
tion, for example, concerning the choice of aspiration versus 
stent retriever application34 or the application of proximal 
flow-arrest to reduce the risk of thrombus fragmentation and 
distal embolization. The respective clot stability or rigidity 
may be associated with clot composition although conclu-
sive and clear study results leading to distinct recommenda-
tions for adapting the interventional technique are lacking. 
Nevertheless, these associations may be further uncovered 
in future studies.
The above findings underscore the importance of charac-
terizing underlying thrombus composition with a known as-
sociation with pathogenesis. Here, we provide evidence that 
it is possible to determine stroke pathogenesis based on a 
novel CT/CTA imaging approach. Measuring thrombus pervi-
ousness with CT imaging is another biomarker and might be 
complementary to the time-consuming histological analysis 
of retrieved thrombi. However, future studies are necessary to 
derive clear therapeutic consequences in the preinterventional 
situation of acute ischemic stroke. Besides diagnostic and 
clinical information, such as duplex sonography, coagulation 
tests, long-term electrocardiography, and echocardiography, 
additional thrombus characteristics will be helpful to deter-
mine the underlying stroke pathogenesis, that could be rele-
vant for therapeutic decisions on secondary stroke prevention.
The approach described herein should be easy to imple-
ment in clinical practice as the perviousness measurement 
can be easily performed. As previously discussed,1 change 
in thrombus attenuation Δ
t
 only requires measurement in the 
thrombus itself, and it is quickly done and relatively robust 
against mistakes. In contrast, the calculation of void fraction ε, 
which represents the porosity of the thrombus, requires a more 
sophisticated performance, and it is not easily implementable 
in the clinical setting of acute ischemic stroke assessment. The 
current analysis of both Δ
t
 and ε showed comparable results 
assuming a sufficient prediction of perviousness by assessing 
change in thrombus attenuation only in the thrombus itself.
Limitations
Our comparisons were performed with acute middle cerebral 
artery occlusions to obtain a homogenous collective with sim-
ilar circumstances in CT/CTA imaging and the subsequent 
recanalization, with an adverse effect on sample size and gen-
eralizability for other intracranial vessel occlusions.
By applying strict inclusion criteria, the study is not 
without the risk of selection bias. But we consider the risk 
of systematic bias to be low as the applied criteria were only 
anatomic and technical and should not have influenced pervi-
ousness itself. Meanwhile, using a homogenous collective by 
applying such inclusion criteria is mandatory to obtain reli-
able and replicable results.
In particular, the unequal distribution of stroke patho-
geneses with more cardioembolic/cryptogenic causes than 
noncardioembolic ones makes further studies necessary to 
reinforce the new insights into thrombus composition and 
pathogenesis by assessing thrombus perviousness measures 
and to implement them in clinical processes. Regarding the 
histological cohort, discrimination between platelets and fi-
brin in the quantitative histological analysis was not possible 
owing to the use of hematoxylin and eosin staining. A correla-
tion of these subcomponents with perviousness measurements 
should be assessed in future studies. In the histological cohort, 
a possible bias could occur as cases with TICI (Thrombolysis 
in Cerebral Infarction) grade 0, where no thrombus material 
could be gathered, are not represented. This bias is not present 
in the validation cohort.
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Regarding the assessment of thrombus perviousness, a 
well-established method was applied with the aim of minimizing 
the influence of baseline thrombus density measures. However, 
in cases of minimal penetration of the contrast agent into the 
thrombus, this may have an influence on assessing high-density 
thrombi because the minimal increase may be masked by high 
baseline density. This possible effect was considered by using 
nonparametric statistical testing. Therefore, a relevant bias from 
this possible effect seems unlikely.
In a minority of cases, patients received imaging in ex-
ternal hospitals and the exact contrast bolus timing could not 
definitively be reconstructed, implying a possible selection 
bias. However, as we only included patients with the afore-
mentioned minimum imaging quality requirements (especially 
concerning slice thickness for adequate thrombus segmenta-
tion), and bolus timing should not have a relevant impact on 
perviousness measurements,23 we consider the possibility of 
a systematic bias arising owing to this limitation to be small.
Summary
Permeable thrombi consist of lower fractions of RBC and more 
FP conglomerations, in turn representing thrombi of cardioem-
bolic origin. Our results suggest that the assessment of thrombus 
perviousness in early and readily available imaging could lead 
to a new imaging marker for identifying stroke mechanism and 
could help to identify potential underlying stroke pathogeneses. 
By implementing these measurements in clinical practice, this 
radiological assessment could aid in predicting cardioembolic 
origin with consequences for therapeutic decisions in the long 
term as well as for secondary stroke prevention.
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